➢ Baseline SAA can be used for predicting response to leflunomide (cut off value 50 mg/L)➢ In spite of a significant reduction in ESR and CRP in RA patients receiving leflunomide, high SAA levels may persist and can be used for detecting subclinical inflammation and adjusting treatment. The gene discussed is SAA2; the disease is rheumatoid arthritis.